Clinical Trial Update: Levocarnitine for Dry Eye in Sjogren's Syndrome [Phase 2]

View source ↗

Summary

Phase 2 trial of levocarnitine for dry eye in Sjögren's syndrome has completed. The study involved Keratoconjunctivitis Sicca as part of the conditions studied.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconjunctivitis Sicca
• Sjögren Syndrome

Drugs mentioned

• LEVOCARNITINE (levocarnitine)

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Sjogren's Syndrome, Keratoconjunctivitis Sicca | Phase 2 | Status: COMPLETED